Type II Heparin-Induced Thrombocytopenia: Toward Developing a Strategy to Determine the Role of Routine Vascular Access Device Heparinization

Author： Rosenthal Kelli  

Publisher： Association of University Programs in Health Administration

ISSN： 1552-8855

Source： Journal of the Association for Vascular Access, Vol.9, Iss.4, 2004-12, pp. : 221-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heparin-induced thrombocytopenia: The role of platelets genetic polymorphisms

By Pamela Scarparo  

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 362-368

Informa Healthcare

Access to resources Recommend Favorite

A New Therapeutic Option by Subcutaneous Recombinant Hirudin in Patients with Heparin-induced Thrombocytopenia Type II - A Pilot Study

By Huhle G.   Hoffmann U.   Hoffmann I.   Liebe V.   Harenberg J.F.   Heene D.L.  

Thrombosis Research, Vol. 99, Iss. 4, 2000-08 ,pp. : 325-334

Elsevier

Access to resources Recommend Favorite

Heparin-induced thrombocytopenia: present and future

By Cuker Adam  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 353-366

Springer Publishing Company

Access to resources Recommend Favorite

New Concepts in Heparin-Induced Thrombocytopenia: Diagnosis and Management

By Spinler Sarah  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 1, 2006-02 ,pp. : 17-21

Springer Publishing Company

Access to resources Recommend Favorite

Emerging Therapy Options in Heparin-Induced Thrombocytopenia

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 50-58

Bentham Science Publishers

Access to resources Recommend Favorite